Leslie Anne Fendt

Dr. Leslie Anne Fendt works at Roche leading the development and commercialization of one of Roche’s first Software-As-Medical-Device (SaMD) products, while simultaneously contributing to building out Roche’s overall digital health infrastructure, operating model, and strategy.

Previously at Roche she was leading the global commercialization of a novel immunology treatment expected to generate >2 billion annual sales by helming a multidisciplinary team of 50 to define its go-to-market strategy and operationalize the product launch across 100+ affiliates. Before that, Leslie held a series of roles in sales, marketing, strategy, insights, and launch excellence both at global and affiliate level.

Leslie holds a master in Organic Chemistry with minors in business and computer science from Uni Basel, CH, and Cambridge, UK, and a PhD in Nanosciences from ETH Zurich. She is a board member of the Swiss Chemical Society and an active voice in the Digital Health/Tech community.